Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
Abstract Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine-mediated beta cell death, there are current...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be8e2bac311c4815b5a158b712b3a6a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:be8e2bac311c4815b5a158b712b3a6a3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:be8e2bac311c4815b5a158b712b3a6a32021-12-02T12:32:52ZTargeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death10.1038/s41598-017-05935-42045-2322https://doaj.org/article/be8e2bac311c4815b5a158b712b3a6a32017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05935-4https://doaj.org/toc/2045-2322Abstract Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine-mediated beta cell death, there are currently no treatments targeting cellular calcium homeostasis to combat type 1 diabetes. Here we show that modulation of cellular calcium homeostasis can mitigate cytokine- and ER stress-mediated beta cell death. The calcium modulating compounds, dantrolene and sitagliptin, both prevent cytokine and ER stress-induced activation of the pro-apoptotic calcium-dependent enzyme, calpain, and partly suppress beta cell death in INS1E cells and human primary islets. These agents are also able to restore cytokine-mediated suppression of functional ER calcium release. In addition, sitagliptin preserves function of the ER calcium pump, sarco-endoplasmic reticulum Ca2+-ATPase (SERCA), and decreases levels of the pro-apoptotic protein thioredoxin-interacting protein (TXNIP). Supporting the role of TXNIP in cytokine-mediated cell death, knock down of TXNIP in INS1-E cells prevents cytokine-mediated beta cell death. Our findings demonstrate that modulation of dynamic cellular calcium homeostasis and TXNIP suppression present viable pharmacologic targets to prevent cytokine-mediated beta cell loss in diabetes.Amy L. ClarkKohsuke KanekuraZeno LavagninoLarry D. SpearsDamien AbreuJana MahadevanTakuya YagiClay F. SemenkovichDavid W. PistonFumihiko UranoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Amy L. Clark Kohsuke Kanekura Zeno Lavagnino Larry D. Spears Damien Abreu Jana Mahadevan Takuya Yagi Clay F. Semenkovich David W. Piston Fumihiko Urano Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death |
description |
Abstract Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine-mediated beta cell death, there are currently no treatments targeting cellular calcium homeostasis to combat type 1 diabetes. Here we show that modulation of cellular calcium homeostasis can mitigate cytokine- and ER stress-mediated beta cell death. The calcium modulating compounds, dantrolene and sitagliptin, both prevent cytokine and ER stress-induced activation of the pro-apoptotic calcium-dependent enzyme, calpain, and partly suppress beta cell death in INS1E cells and human primary islets. These agents are also able to restore cytokine-mediated suppression of functional ER calcium release. In addition, sitagliptin preserves function of the ER calcium pump, sarco-endoplasmic reticulum Ca2+-ATPase (SERCA), and decreases levels of the pro-apoptotic protein thioredoxin-interacting protein (TXNIP). Supporting the role of TXNIP in cytokine-mediated cell death, knock down of TXNIP in INS1-E cells prevents cytokine-mediated beta cell death. Our findings demonstrate that modulation of dynamic cellular calcium homeostasis and TXNIP suppression present viable pharmacologic targets to prevent cytokine-mediated beta cell loss in diabetes. |
format |
article |
author |
Amy L. Clark Kohsuke Kanekura Zeno Lavagnino Larry D. Spears Damien Abreu Jana Mahadevan Takuya Yagi Clay F. Semenkovich David W. Piston Fumihiko Urano |
author_facet |
Amy L. Clark Kohsuke Kanekura Zeno Lavagnino Larry D. Spears Damien Abreu Jana Mahadevan Takuya Yagi Clay F. Semenkovich David W. Piston Fumihiko Urano |
author_sort |
Amy L. Clark |
title |
Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death |
title_short |
Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death |
title_full |
Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death |
title_fullStr |
Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death |
title_full_unstemmed |
Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death |
title_sort |
targeting cellular calcium homeostasis to prevent cytokine-mediated beta cell death |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/be8e2bac311c4815b5a158b712b3a6a3 |
work_keys_str_mv |
AT amylclark targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT kohsukekanekura targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT zenolavagnino targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT larrydspears targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT damienabreu targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT janamahadevan targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT takuyayagi targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT clayfsemenkovich targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT davidwpiston targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath AT fumihikourano targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath |
_version_ |
1718393944205688832 |